Takeda Announces Unblinding of Phase 3 Study of Orteronel in Patients with...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it has unblinded the ELM-PC 5 Phase 3 study (C21005) of orteronel plus prednisone compared...
View Article医疗保健高管认为协作可改善最终成果,但要成功却实属不易
北卡罗来纳州研究三角园区 (美国商业资讯)–昆泰的一份最新报告探讨了医疗保健行业高管对协作需求以及他们在协作中所面临挑战的理解,该报告基于一项对全球生物制药业、支付方和供应方高管的调查。 《协作要求》(The Collaboration...
View ArticleOtsuka Receives Opinion from CHMP on Delamanid
GENEVA Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for...
View ArticleDr. Reddy’s Q1 FY14 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated financial results for the quarter ended June 30, 2013 under International Financial Reporting...
View ArticleBaxter and JW Holdings Announce Exclusive Global Development and...
DEERFIELD, Ill. Baxter International Inc. (NYSE:BAX) and JW Holdings today announced that they have entered into an exclusive distribution and license agreement for parenteral nutritional products...
View ArticleAstraZeneca and FibroGen Collaborate to Develop and Commercialize FG-4592, a...
SAN FRANCISCO AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage...
View ArticleNerviano Medical Sciences与施维雅宣布缔结一项抗癌新药的合作和授权协议
意大利NERVIANO和法国SURESNES (美国商业资讯)–Nerviano Medical...
View ArticleCell Signaling Technology, Inc.发布个体化癌症诊断试剂的授权
马萨诸塞州DANVERS — (美国商业资讯) –马萨诸塞州Danvers的Cell Signaling Technology, Inc. (CST)今天宣布,将CST用于PCR(聚合酶链式反应)诊断检测领域的ALK基因重排检测相关的世界范围的非排他性专利权授予Cepheid,...
View ArticleU.S. Food and Drug Administration’s Cardiovascular and Renal Drugs Advisory...
TOKYO Otsuka Pharmaceutical Co., Ltd. announced today the U.S. Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee voted 9 to 6 not to approve tolvaptan for the...
View ArticleCytori’s Celution® System Approved in Australia for Processing and Delivering...
SAN DIEGO Cytori Therapeutics (NASDAQ: CYTX) has received notice from the Australian Therapeutic Goods Administration (TGA) that the Celution® System is approved for commercial use through inclusion...
View ArticleNew High-Tech Laser Method Allows DNA to be Inserted ‘Gently’ into Living Cells
WASHINGTON The applications of gene therapy and genetic engineering are broad: everything from pet fish that glow red to increased crop yields worldwide to cures for many of the diseases that plague...
View ArticleAmpliPhi Presents Data on Bacteriophages in the Treatment of Lung Infections...
RICHMOND, Va. & SYDNEY & LONDON AmpliPhi BioSciences Corp. (OTC: APHB) (“AmpliPhi”), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant...
View ArticleBIO Convention in China 2013 to be held Nov 11 – 13, 2013, in Beijing, CN
WASHINGTON Press Kit Materials are Available at: http://www.tradeshownews.com/events/BIO-Convention-in-China-2013/OnlinePressKit/ Company: Biotechnology Industry Organization (BIO) Event: BIO...
View Article昆泰在 I期临床研究市场报告中被誉为首选提供商
北卡罗来纳州研究三角园区 (美国商业资讯)–根据行业标准研究(ISR)2013年I期临床研究发展趋势和市场展望报告(2013 Phase I Study Trends and Market Outlook...
View Article